CytoMed Therapeutics Limited Profit Loss Before Tax
CytoMed Therapeutics Limited (GDTC) reported Profit Loss Before Tax of -SGD 4.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:ProfitLossBeforeTax · last filed 2026-03-31
SGD
| Period end | Profit Loss Before Tax 12 month |
|---|---|
| 2025-12-31 | -4.00M SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | -2.52M SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | -4.13M SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | -3.13M SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | -2.05M SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | -1.94M SGD 20-F · filed 2023-05-01 |
USD
| Period end | Profit Loss Before Tax 12 month |
|---|---|
| 2025-12-31 | -$3.11M 20-F · filed 2026-03-31 |
| 2024-12-31 | -$1.85M 20-F · filed 2025-04-28 |
| 2023-12-31 | -$3.13M 20-F · filed 2024-04-22 |
| 2022-12-31 | -$2.33M 20-F · filed 2023-05-01 |